Eamonn Quigley, MD

  • Houston Methodist gastroenterologist
  • Chief, Houston Methodist Hospital division of gastroenterology and hepatology
  • Director, Houston Methodist Lynda K. and David M. Underwood Center for Digestive Disorders
  • David M. Underwood Chair of Medicine in Digestive Disorders at Houston Methodist Hospital
  • Professor of medicine, Houston Methodist Research Institute

Eamonn Quigley, MD

Areas of Expertise

  • Biomarkers for IBS
  • C. diff/Fecal transplants
  • Celiac disease
  • Chronic constipation
  • Functional GI disorders
  • Gastroesophogeal reflux disease (GERD)
  • Gastroparesis
  • Gut microbiome
  • Irritable bowel syndrome
  • Motility issues
  • Neurogastroenterology
  • Probiotics

Credentials

FELLOWSHIP
Gastroenterology
BOARD CERTIFICATION
Gastroenterology | American Board of Internal Medicine
MEDICAL SCHOOL
University College Cork School of Medicine, Cork, Ireland | 1976
RESIDENCY
Western Infirmary & Association Hospital, Glasgow, Scotland | 1977
INTERNSHIP
St. Finbarrs Hospital, Cork, Ireland | 1976

Publications

Abnormal balloon expulsion test in patients with fecal incontinence
Neshatian, L, Fosso, CL & Quigley, EM 2020, , Journal of Gastrointestinal and Liver Diseases, vol. 29, no. 3, pp. 345-351. https://doi.org/10.15403/jgld-2273

Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis
Black, CJ, Thakur, ER, Houghton, LA, Quigley, EMM, Moayyedi, P & Ford, AC 2020, , Gut, vol. 69, no. 8, pp. 1441-1451. https://doi.org/10.1136/gutjnl-2020-321191

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic
Holtmann, G, Quigley, EM, Shah, A, Camilleri, M, Tan, VPY, Gwee, KA, Sugano, K, Sollano, JD, Fock, KM, Ghoshal, UC, Chen, M, Dignass, A & Cohen, H 2020, , Journal of Gastroenterology and Hepatology (Australia), vol. 35, no. 7, pp. 1117-1123. https://doi.org/10.1111/jgh.15133


Irritable bowel syndrome in celiac disease - relationships to celiac disease antibodies and levels of pro-inflammatory cytokines
Olano, C, López, V, Freire, T, Rodríguez, X, Pontet, Y, Alemán, A, Rodríguez, N, Rovira, L, Trucco, E, Osinaga, E, Cohen, H & Quigley, EM 2020, , Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú, vol. 40, no. 2, pp. 127-135.

Nutraceuticals as modulators of gut microbiota: Role in therapy
Quigley, EMM 2020, , British Journal of Pharmacology, vol. 177, no. 6, pp. 1351-1362. https://doi.org/10.1111/bph.14902


Cancer cachexia: A multifactoral disease that needs a multimodal approach
Stubbins, R, Bernicker, EH & Quigley, EM 2020, , Current opinion in gastroenterology, vol. 36, no. 2, pp. 141-146. https://doi.org/10.1097/MOG.0000000000000603

Polyethylene glycol-based laxatives for chronic constipation – Authors' reply
Luthra, P, Camilleri, M, Burr, NE, Quigley, EMM, Black, CJ & Ford, AC 2020, , The Lancet Gastroenterology and Hepatology, vol. 5, no. 2, pp. 110-111. https://doi.org/10.1016/S2468-1253(19)30381-4


Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
Black, CJ, Yuan, Y, Selinger, CP, Camilleri, M, Quigley, EMM, Moayyedi, P & Ford, AC 2020, , The Lancet Gastroenterology and Hepatology, vol. 5, no. 2, pp. 117-131. https://doi.org/10.1016/S2468-1253(19)30324-3

Antibiotics and probiotics in inflammatory bowel disease: When to use them?
Abraham, B & Quigley, EMM 2020, , Frontline Gastroenterology, vol. 11, no. 1, pp. 62-69. https://doi.org/10.1136/flgastro-2018-101057


Commentary: faecal microbiota transplantation—from home brew to holy grail
Quigley, EM 2020, Alimentary Pharmacology and Therapeutics, vol. 51, no. 1, pp. 208-209. https://doi.org/10.1111/apt.15553

Choosing a Prokinetic for Your Patient Beyond Metoclopramide
Gudsoorkar, V & Quigley, EM 2020, The American Journal of Gastroenterology, vol. 115, no. 1, pp. 5-8. https://doi.org/10.14309/ajg.0000000000000463


Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis
Black, CJ, Burr, NE, Camilleri, M, Earnest, DL, Quigley, EMM, Moayyedi, P, Houghton, LA & Ford, AC 2020, , Gut, vol. 69, no. 1, pp. 74-82. https://doi.org/10.1136/gutjnl-2018-318160

Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation
Rao, SSC, Lembo, A, Chey, WD, Friedenberg, K & Quigley, EM 2020, Neurogastroenterology and Motility. https://doi.org/10.1111/nmo.13890

The microbiome and inflammatory bowel disease
Glassner, KL, Abraham, BP & Quigley, EMM 2020, , Journal of Allergy and Clinical Immunology, vol. 145, no. 1, pp. 16-27. https://doi.org/10.1016/j.jaci.2019.11.003


Languages

  • English